Applied BioMath

Applied BioMath is a leading biotechnology research company dedicated to accelerating and de-risking drug research and development. Specializing in Model-Informed Drug Discovery and Development (MID3), Applied BioMath offers comprehensive services, cutting-edge software, and robust R&D capabilities to support pharmaceutical and biotechnology companies worldwide. Applied BioMath is committed to providing quantitative and predictive guidance to enhance decision-making throughout the drug development lifecycle. The primary address of Applied BioMath is 561 Virginia Rd, Concord, Massachusetts 01742, US, with additional locations at 210 Broadway, Suite 201, Cambridge, MA 02139, US, and 1111 Broadway, 3rd Floor, Oakland, CA 94607, US.

Leveraging a Model-Aided Drug Invention (MADI) approach, Applied BioMath employs proprietary algorithms and software to provide data-driven insights from early research through clinical trials. This approach allows Applied BioMath to help its partners better understand their drug candidates, optimize critical parameters, identify competitive advantages, and determine the best path forward for clinical success. Applied BioMath's commitment to innovation and excellence makes it a trusted partner in the biotechnology and pharmaceutical industries.

Applied BioMath continues to expand its capabilities and services, remaining at the forefront of biotechnology research. With a focus on delivering exceptional value and driving successful outcomes, Applied BioMath is dedicated to shaping the future of drug discovery and development. We invite the manager of Applied BioMath to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence and connect with potential partners and clients.